Filter
219
Text search:
Stimulants
Featured
Recommendations
16
New Publications
31
Language
Document type
No document type
159
Studies & Reports
19
Guidelines
19
Training Material
7
Manuals
4
Strategic & Response Plan
4
Brochures
3
Situation Updates
2
Infographics
1
Fact sheets
1
Countries / Regions
India
9
Ukraine
7
Western and Central Europe
6
Kenya
4
Nigeria
3
Namibia
3
Asia
3
Global
3
Congo, Democratic Republic of
2
Ethiopia
2
Haiti
2
South Africa
2
Eastern Europe
2
Russia
2
Vietnam
2
Cameroon
1
Uganda
1
Zimbabwe
1
Philippines
1
Nepal
1
Lebanon
1
Syria
1
Chad
1
Sudan
1
Benin
1
Eswatini/ Swaziland
1
Serbia
1
Botswana
1
Myanmar / Burma
1
South–East Asia Region
1
Latin America and the Carribbean
1
Africa
1
Tajikistan
1
Moldova
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
37
Clinical Guidelines
12
Public Health
7
Women & Child Health
4
Key Resources
2
Capacity Building
1
Toolboxes
Mental Health
115
HIV
35
Pharmacy
6
Refugee
4
COVID-19
4
AMR
3
Caregiver
3
Planetary Health
3
TB
2
Global Health Education
2
NTDs
2
NCDs
2
Ebola & Marburg
1
Cholera
1
Conflict
1
Natural Hazards
1
Rapid Response
1
Specific Hazards
1
2.0 Rapid Response
1
The pamphlet "Methamphetamine" provides information about methamphetamine, an illegal stimulant with high abuse potential, though it has limited medical uses for conditions like ADHD and narcolepsy. It explains short-term effects such as appetite suppression, increased heart rate and blood pressure,
...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market fo
...
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulant
...
Volume 20, September
Global smart update
Accessed: 22.03.2019
Q2: What interventions are safe and effective for drug withdrawal (cannabis, amphetamines, cocaine, benzodiazepines, and inhalants)?
Q8: What is the effectiveness, safety and role of pharmacological interventions, by non-specialized health care providers, for the broad category of Disruptive Behaviour Disorders (DBDs), Conduct Disorder (CD), Oppositional Defiant Disorder (ODD) and comorbid (but not exclusively) Attention-Deficit
...
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (which may or may not have been medically prescribed)
...
Accessed: 14.03.2019
Q7: What is the effectiveness, safety and role of pharmacological and non-pharmacological interventions, within non- specialist health care for children with a diagnosis of Attention-deficit hyperactivity disorder (ADHD)?
Déclaration d’Astana
recommended
Conférence internationale sur les soins de santé primaires d’Alma-Ata à la couverture sanitaire universelle et aux objectifs de développement durable , Astana, Kazakhstan, 25 et 26 octobre 2018
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination
...
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
Externalizing disorders
Chapter 1.1
European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206
This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.
